Title: Ozer HG, et al. BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor. Cancer Discov. 2018 Apr;8(4):458-477.
1428774-45-1 | PF-06459988 | AA01EO64 | MFCD28987462
1189767-28-9 | BI-409306 | AA01EOCI | MFCD31746892
1104599-69-0 | MK-4256 | AA01EOHG | MFCD25976577
1805789-54-1 | CT7001 hydrochloride | AA01EONC | MFCD31657343
1435934-29-4 | (1-(6-hydroxyhexyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | AA01EOUQ | MFCD27966187
143673-93-2 | 1,1'-(1,8-dioxo-1,8-octanediyl)bis[glycyl-glycine | AA01EP31
97512-83-9 | S-(phenylsulfonyl)-L-cysteine | AA01EPD7
1286430-01-0 | 7-chloro-5-(2-fluorophenyl-d4)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | AA01EPJE | MFCD01861526
934293-92-2 | 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-4,5,7-d3 | AA01EPOV | MFCD06658853
140715-86-2 | (1'R,2S,3'S,5'S,9aS)-1,4',5',9a-tetrahydro-1',2-dimethyl-spiro[9H-imidazo[1,2-a]indole-9,3'-[1,5](iminomethano)[3H][1,4]oxazepino[3,4-b]quinazoline]-3,7',13'(1'H,2H)-trione | AA01EPVZ
